Nuritas lab
Why We Exist

Revolutionize human health at scale to improve the lives of billions.

To discover nature's smartest bioactive peptides with AI and validate them with proven clinical outcomes — making healthier ingredients accessible to every person, in every product.

The Founder

Dr. Nora Khaldi is a mathematician who decided the most important equation she could solve was human health.

Trained to find patterns and solve problems, Nora founded Nuritas knowing that nature held answers science hadn't found yet. Over one billion potential peptides exist in plants alone — yet traditional discovery methods test them one by one, taking decades and costing hundreds of millions. Meanwhile, two-thirds of consumers don't trust the health claims brands make. Nora built Nuritas to change both. Using AI to discover and clinically validate nature's most powerful peptides — making genuinely healthier ingredients accessible to all.

Dr. Nora Khaldi

Founder & CEO  ·  Ph.D. Molecular Evolution & Bioinformatics
Dr. Nora Khaldi
Team Leadership

An incredible pioneering team.

A diverse team of scientists, AI specialists, and industry experts — united by one goal. Based in Dublin, in a state-of-the-art research facility.

Dr Nora Khaldi

Dr. Nora Khaldi

Founder & CEO

John Casey

John Casey

Chief Manufacturing & Supply Chain Officer

Conor Walshe

Conor Walshe

Chief Financial Officer

Alison Anderson

Alison Anderson

Chief People Officer

Governance & Counsel

The people who shape
our direction.

Underpinned by strong corporate governance — a board with deep expertise across science, finance, and global markets, supported by world-class advisors.

Board of Directors
Dr. Alan Barton

Dr. Alan Barton

Chairman

M.Chem Oxford, Ph.D. Organic Chemistry Harvard. Specialty materials industry leader.

Alex Seddon

Alex Seddon

M&G Investments

Head of Impact & Private Equity. Leads M&G's Catalyst strategy and investing in public & private markets since 2003.

Randall Lewis

Randall Lewis

Cleveland Avenue

Managing Partner. 30+ years finance including GE Capital and Wells Fargo.

Matthieu Vermesch

Matthieu Vermesch

VisVires New Protein

Founder & Managing Partner, Clay Capital. 25+ years investment management.

Dr Nora Khaldi

Dr. Nora Khaldi

Founder & CEO

Executive Director. Ph.D. Molecular Evolution & Bioinformatics.

Henry McGovern

Henry McGovern

McWin Capital Partners

Co-founder of McWin Capital Partners. Founded AmRest Holdings, growing it to 2,300+ locations. Forbes Top 5 Businesspeople in Poland 2008.

Advisory Board
Indra Nooyi

Indra Nooyi

Former CEO & Chairperson, PepsiCo. Amazon Board Member.

Dr. Will Li

Dr. Will Li

Founder, Angiogenesis Foundation. Author, Eat to Beat Disease. 11M TED Talk views.

Joerg Ohle

Joerg Ohle

Former Head of Commercial Operations, Bayer. 40+ years consumer health.

Prof J Bruce German

Prof. J Bruce German

Director, Foods for Health Institute, UC Davis.

Our Investors

Backed by the best.

From global institutions to some of the world's most visionary individuals — the people who believe in what we're building.

Bono

Bono

Co-founder, ONE & RED

The Edge

The Edge

U2

Marc Benioff

Marc Benioff

Founder & CEO, Salesforce

Ali Partovi

Ali Partovi

Code.org co-founder

M&G Investments McWin Capital Partners Cleveland Avenue Cultivian Sandbox ECBF Grupo Nutresa Cheil Jedang Enterprise Ireland Veronorte Vertex Ventures Grosvenor Clay Capital
Our History

Learning to speak
the language of life.

2014

Nuritas founded in Dublin

Dr. Nora Khaldi founds Nuritas with the vision of using AI to unlock bioactive peptides hidden in nature.

2015 – 2017

First AI platform built & early peptide discoveries

The Nuritas Magnifier takes shape. First AI-identified peptides validated in preclinical studies. Bono, The Edge, and Marc Benioff invest.

2018 – 2020

PeptiStrong® & PeptiYouth™ discovery

AI identifies lead candidates from fava bean and rice proteins. Human clinical trials begin. First peer-reviewed papers published in leading journals.

2021 – 2024

Commercialisation — ingredients reach market

PeptiStrong®, PeptiSleep™ and PeptiYouth™ commercially launched. Partnerships with leading global brands. 56 patents issued.

2025 – 2026

Landmark BMJ clinical trial published. SmartPeptides™ in 100+ products worldwide.

Randomised, double-blind, placebo-controlled study on PeptiStrong® published in BMJ Nutrition, Prevention & Health. Nuritas peptides now in over 100 products globally, serving up over 200 million doses so far.